These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Membrane-initiated nongenomic effect on mitogen-activated protein kinase signal transduction of estrogen in endometrial carcinoma cell].
    Author: Zhang LL, Li XP, Wang JL, Wei LH.
    Journal: Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):615-8. PubMed ID: 19087499.
    Abstract:
    OBJECTIVE: To study the nongenomic effect on mitogen-activated kinase (MAPK) signal transduction of 17beta-estradiol at plasma membrane in endometrial cancer cell Ishikawa. METHODS: Estradiol-bovine serum albumin conjugates (E(2)-BSA) was added to Ishikawa cells at different time points. Western blot was used to detect the protein expression of phosphorylated extracellular signal-regulated kinase (ERK) 1/2. Confocal was used to verify if the phosphorylation of ERK1/2 was initiated at the membrane. RESULTS: Phosphorylation of ERK1/2 was elicited after 5 minute exposure to 1 x 10(-7) mol/L E(2)-BSA. It was induced to a maximum following 60 minute exposure and descended after 2 hours. The expression levels of phosphorylated ERK1/2 were 0.52, 0.98, and 0.09, respectively. Confocal proved that E(2)-BSA combined with membrane receptors after 5 minutes and elevated the phosphorylation of ERK1/2. CONCLUSION: Membrane actions of estrogen can activate the rapid signaling cascades of MAPK in endometrial carcinoma cells.
    [Abstract] [Full Text] [Related] [New Search]